Form 10-Q WINDTREE THERAPEUTICS For: Mar 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- S&P 500, Nasdaq set to open higher as AI stocks rebound ahead of earnings rush
- U.S. economy is "booming," JPMorgan’s Dimon says
- Musk pledges one share of SpaceX to every U.S. child
- Oil slips from five-month high with Hormuz transits in focus
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
- Brazil's Bolsonaro, Lula spar in first debate as personal attacks fly
- S&P 500, Nasdaq set to open higher as AI stocks rebound ahead of earnings rush
- Microsoft pulls out of UK data center deal with Nscale, Telegraph reports
- AST SpaceMobile partners with four European operators on MSS spectrum
- Lithuanians forced to take shelter after suspected drone enters airspace
Windtree Therapeutics (WINT) Misses Q1 EPS by 12c
May 12, 2016 7:21 AM EDTWindtree Therapeutics (NASDAQ: WINT) reported Q1 EPS of ($1.70), $0.12 worse than the analyst estimate of ($1.58). Revenue for the quarter came in at $75 thousand, versus $191 thousand reported last year.
For earnings history and earnings-related data on Windtree Therapeutics (WINT) click here.
... More


